title: FK 506 and rapamycin do not affect platelet aggregation or mitochondrial function.
authors.affiliation: School of Biological Sciences, University of Sussex, Brighton, UK.
authors.forename: V
authors.initials: V
authors.lastname: Pelekanou
authors.forename: A E
authors.initials: AE
authors.lastname: Trezise
authors.forename: A L
authors.initials: AL
authors.lastname: Moore
authors.forename: J E
authors.initials: JE
authors.lastname: Kay
mesh_terms: D000818:Animals; D016572:Cyclosporine / Q000494:pharmacology; D003524:Cyclosporins / Q000494:pharmacology; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008930:Mitochondria, Liver / Q000187:drug effects / Q000502:physiology*; D008933:Mitochondrial Swelling / Q000187:drug effects*; D010101:Oxygen Consumption / Q000187:drug effects; D010974:Platelet Aggregation / Q000187:drug effects*; D011090:Polyenes / Q000494:pharmacology*; D051381:Rats; D020123:Sirolimus; D016559:Tacrolimus / Q000494:pharmacology*
chemical_list: D003524:Cyclosporins; D007166:Immunosuppressive Agents; D011090:Polyenes; C045571:cyclosporin G; D016572:Cyclosporine; D020123:Sirolimus; D016559:Tacrolimus